Jay Kang
Executive Director, Head of CMC and External Manufacturing (Cell and Gene Therapy),
Legend Biotech
With over 20 years of experience in biologics development and manufacturing, including successful contributions to four BLAs, he leads CMC and External Manufacturing for Cell & Gene Therapy at Legend Biotech. His expertise spans monoclonal antibodies, enzymes, vaccines, gene therapies, cell therapies, and CAR‑T, including Carvykti and in vivo LV CMC development. A proven people leader, he has built high‑performing teams and driven global operational excellence across CROs and CDMOs. He is a recognized industry expert with 20+ publications and deep regulatory experience in analytical development, process validation, cGMP manufacturing, and IND/BLA strategy, overseeing budgets exceeding $100M.
Sessions


